NIH-funded research R01 grant

Investigating genetic factors contributing to liver cancer in African Americans

Official title: Genetic Epidemiology of Hepatocellular Carcinoma in African Americans

Funded at Baylor College of Medicine · NIH-10894325 · Data updated 2026-11-12

This study is looking at how genetics might play a role in the higher rates of liver cancer in African Americans, and it's gathering information from many patients to help find better ways to prevent and treat this condition.

More Carcinoma research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 26, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$347,701
NIH project number5R01CA274528-02
Project IDNIH-10894325 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American individuals who are at risk for or have been diagnosed with hepatocellular carcinoma.

Less likely to help

Patients who are not of African descent or those without risk factors for liver cancer may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors that may increase the risk of hepatocellular carcinoma (HCC) specifically in African Americans. By conducting a genome-wide association study (GWAS), the researchers aim to identify genetic variations that contribute to the higher incidence of HCC in this population compared to non-Hispanic whites. The study will collect comprehensive genetic, epidemiological, and environmental data from a large cohort of African American cancer patients to better understand the underlying causes of this disparity. The findings could lead to improved prevention strategies and targeted interventions for those at risk.

Why it matters

Potential benefit: If successful, this research could lead to better risk assessment and prevention strategies for liver cancer in African Americans.

How similar studies have gone: Previous genome-wide association studies in other populations have successfully identified genetic risk factors for hepatocellular carcinoma, suggesting potential for similar success in this research.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Thrift, Aaron Peter — Baylor College of Medicine
  • Study coordinator: Thrift, Aaron Peter

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.